MedTrace Logo

Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System

NCT00267449 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 950

Last updated 2007-09-11

No results posted yet for this study

Summary

The primary study endpoint -SoftScan adjunctive accuracy- will be used to test the hypothesis that the adjunctive combination of the SoftScan with x-ray mammography provides diagnostic accuracy that is significantly better than x-ray mammography alone.

Conditions

Interventions

DEVICE

SoftScan Optical Breast Imaging System

Sponsors & Collaborators

  • ART Advanced Research Technologies Inc.

    lead INDUSTRY

Principal Investigators

  • Joseph G Kozikowski, MD · ART Advanced Research Technologies Inc.

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00267449 on ClinicalTrials.gov